March 2016 FDA Recall Drug by Quva Pharma, Inc.
D-1066-2016 - Labeling

This Class I drug recall was voluntarily initiated by Quva Pharma, Inc. on March 30, 2016 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed in CA and the recall is currently terminated.

Recall Number: D-1066-2016

Reason for Recall
Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.
Initiated
03-30-2016
Reported
07-13-2016
Quantity
20 cases

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx only, Healix Infusion Therapy Inc, 1075 W Park One Drive, Suite 200, Sugar Land Texas 77478, Product Code: 75901-1205-35.

Batch or Lot Expiration Information

Lot# : 14312-0, Exp 4/15/2016